| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2017-11-21 17:39:33 UTC |
|---|
| Update Date | 2022-03-07 03:18:14 UTC |
|---|
| HMDB ID | HMDB0240233 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | Mizolastine |
|---|
| Description | Mizolastine, also known as mizollen or mistalin, belongs to the class of organic compounds known as benzimidazoles. These are organic compounds containing a benzene ring fused to an imidazole ring (five member ring containing a nitrogen atom, 4 carbon atoms, and two double bonds). In humans, mizolastine is involved in the mizolastine h1-antihistamine action pathway. Mizolastine is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. Based on a literature review a significant number of articles have been published on Mizolastine. |
|---|
| Structure | CN(C1CCN(CC1)C1=NC2=CC=CC=C2N1CC1=CC=C(F)C=C1)C1=NC=CC(O)=N1 InChI=1S/C24H25FN6O/c1-29(23-26-13-10-22(32)28-23)19-11-14-30(15-12-19)24-27-20-4-2-3-5-21(20)31(24)16-17-6-8-18(25)9-7-17/h2-10,13,19H,11-12,14-16H2,1H3,(H,26,28,32) |
|---|
| Synonyms | | Value | Source |
|---|
| Mizollen | Kegg | | Mistalin | MeSH | | Mistamine | MeSH | | Mizolen | MeSH | | Zolim | MeSH | | Zolistan | MeSH | | MKC 431 | HMDB | | SL 850324 | HMDB | | Mizolastine | HMDB, MeSH | | Galderma brand OF mizolastine | MeSH, HMDB | | Sanofi synthelabo brand OF mizolastine | MeSH, HMDB | | Allphar brand OF mizolastine | MeSH, HMDB | | Novag brand OF mizolastine | MeSH, HMDB | | Schwarz brand OF mizolastine | MeSH, HMDB |
|
|---|
| Chemical Formula | C24H25FN6O |
|---|
| Average Molecular Weight | 432.503 |
|---|
| Monoisotopic Molecular Weight | 432.207387612 |
|---|
| IUPAC Name | 2-[(1-{1-[(4-fluorophenyl)methyl]-1H-1,3-benzodiazol-2-yl}piperidin-4-yl)(methyl)amino]pyrimidin-4-ol |
|---|
| Traditional Name | zolim |
|---|
| CAS Registry Number | 108612-45-9 |
|---|
| SMILES | CN(C1CCN(CC1)C1=NC2=CC=CC=C2N1CC1=CC=C(F)C=C1)C1=NC=CC(O)=N1 |
|---|
| InChI Identifier | InChI=1S/C24H25FN6O/c1-29(23-26-13-10-22(32)28-23)19-11-14-30(15-12-19)24-27-20-4-2-3-5-21(20)31(24)16-17-6-8-18(25)9-7-17/h2-10,13,19H,11-12,14-16H2,1H3,(H,26,28,32) |
|---|
| InChI Key | PVLJETXTTWAYEW-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as benzimidazoles. These are organic compounds containing a benzene ring fused to an imidazole ring (five member ring containing a nitrogen atom, 4 carbon atoms, and two double bonds). |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Benzimidazoles |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Benzimidazoles |
|---|
| Alternative Parents | |
|---|
| Substituents | - Benzimidazole
- Dialkylarylamine
- Aminopyrimidine
- Fluorobenzene
- Hydroxypyrimidine
- Halobenzene
- Aminoimidazole
- Aryl fluoride
- Aryl halide
- Monocyclic benzene moiety
- N-substituted imidazole
- Piperidine
- Pyrimidine
- Benzenoid
- Imidazole
- Azole
- Heteroaromatic compound
- Azacycle
- Organohalogen compound
- Hydrocarbon derivative
- Organopnictogen compound
- Organofluoride
- Organonitrogen compound
- Organooxygen compound
- Organic nitrogen compound
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 5.34 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 11.763 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.45 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1255.0 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 196.8 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 202.2 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 173.6 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 119.1 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 421.7 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 514.4 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 197.1 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1016.5 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 316.8 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1236.7 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 277.9 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 354.3 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 305.0 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 237.9 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 7.9 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized |
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Mizolastine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Mizolastine LC-ESI-qTof , Positive-QTOF | splash10-0a4i-0011900000-375df4a855e43dfec509 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Mizolastine LC-ESI-qTof , Positive-QTOF | splash10-001i-0721900000-53e1c9b1a9ae2a2a816d | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Mizolastine , positive-QTOF | splash10-0a4i-0011900000-375df4a855e43dfec509 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Mizolastine , positive-QTOF | splash10-056s-1924000000-3222d3ee56cb73f00360 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Mizolastine , positive-QTOF | splash10-001i-0721900000-53e1c9b1a9ae2a2a816d | 2017-09-14 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mizolastine 10V, Positive-QTOF | splash10-001i-0001900000-0e5d2656f8bcd8e6fa1d | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mizolastine 20V, Positive-QTOF | splash10-001i-0202900000-d6b156878fd68891b0b1 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mizolastine 40V, Positive-QTOF | splash10-004i-6910000000-f017d9c52b7afbdc1c46 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mizolastine 10V, Negative-QTOF | splash10-001i-0000900000-fc483485f696bcdee646 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mizolastine 20V, Negative-QTOF | splash10-000x-7305900000-bbc66768aebdabf20515 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mizolastine 40V, Negative-QTOF | splash10-006x-9300000000-61079a3121742b38570e | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mizolastine 10V, Negative-QTOF | splash10-001i-0000900000-81d17ba50274d8e0b8f6 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mizolastine 20V, Negative-QTOF | splash10-001i-1002900000-c509b3df8a551503dcfa | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mizolastine 40V, Negative-QTOF | splash10-01t9-2329600000-fc9cc2eac19fd4b77f44 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mizolastine 10V, Positive-QTOF | splash10-001i-0000900000-4ed9034a988b18f0c28d | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mizolastine 20V, Positive-QTOF | splash10-001i-0000900000-aef04151f343101f583a | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mizolastine 40V, Positive-QTOF | splash10-0a4i-0329100000-c701769d627b3e3134e9 | 2021-09-22 | Wishart Lab | View Spectrum |
|
|---|